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Abstract 7 
Brown seaweeds have been highlighted for their abundant production of bioactive 8 
substances that may provide novel drugs or drug scaffolds for a range of diseases, 9 
particularly cancer. Indeed, a number of promising compounds that can modulate 10 
growth arrest or apoptosis have already been isolated. As previous work has 11 
highlighted seasonal differences in concentrations of secondary metabolites, this study 12 
aimed to evaluate seasonal variation in the cytotoxic anticancer activity of Cystoseira 13 
tamariscifolia extracts. Primary and secondary metabolites were measured using 14 
colourimetric techniques and extracts were exposed to human leukaemia, HL60 and 15 
THP-1, and human prostate cancer PC3 cell lines in vitro and cell viability was 16 
measured using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide 17 
(MTT) assay. The results confirm a large but inconsistent seasonal variation in the 18 
concentrations of biomolecules, although, generally, levels were higher in spring and 19 
summer. IC50 values for cytotoxicity also showed variability both seasonally and with 20 
extraction protocol, but again, this was inconsistent. These data suggest that, when 21 
collecting brown algae in order to isolate novel bioactive compounds, repeated 22 
sampling across annual or biotic cycles of the seaweed and the use of multiple solvent 23 
extraction methods could give a greater possibility of discovering bioactive-lead 24 
compounds. 25 
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Introduction 28 
Cancer has become one of the major causes of premature death in an ageing 29 
population. With the risk of developing cancer approaching 50% by the age of 80, 30 
combined with current life expectancy figures that are increasing in developing 31 
countries, cancer is likely to remain a major affliction to patients and a challenge to 32 
healthcare services. Prostate cancer remains one of the leading causes of cancer-33 
related death, while 6.8 million cancer deaths reported globally in 2018, 1.8 million of 34 
which were caused by prostate cancer only. Not far from that, leukaemia of various 35 
types, also claiming many lives around the world every year, especially children (Siegel 36 
et al. 2019; Bray et al. 2018), which makes the search for a cure for these fatal 37 
diseases a noble goal of our research. The most common treatments for cancer are 38 
still surgery, radiotherapy and chemotherapy, including direct and indirect hormonal 39 
and immune therapies (Coffelt and de-Visser 2015; Senthebane et al. 2017). 40 
Currently, most of the chemotherapeutic strategies used to treat different cancers are 41 
not completely effective and are often associated with severe side effects that can 42 
significantly reduce the quality of life of the patient. Thus, much research is being 43 
dedicated to finding novel compounds that show clinical efficacy with reduced side 44 
effects, with much of this research concentrated on natural products including those 45 
from marine algae (Anand et al. 2016). Bioactive compounds from brown seaweeds 46 
have been highlighted for their importance as anticancer agents (Ashwini et al. 2016) 47 
and most of these compounds are generally safe and are abundant in brown 48 
seaweeds, which make them a promising potential source of therapeutic compounds 49 
(Zubia et al. 2009). A wide range of these bioactive ingredients has been reported to 50 
have anti-tumour activity. Polyphenols have been linked with anticancer activities of 51 
seaweed crude extracts, for instance, phloroglucinol and dioxinodehydroeckol from 52 
brown algae display an antiproliferative activity against colon and breast tumours 53 
(Lopes-Costa et al. 2017; Murphy et al. 2014). Similarly, phloroglucinol from an 54 
Ecklonia cava extract showed apoptosis enhancing effects on the MCF-7 human 55 
breast cancer cell line (Kong et al. 2009). Furthermore, crude extracts from brown 56 
algae Palmaria palmata, Laminaria setchellii and Macrocystis integrifolia exhibited 57 
cytotoxicity against the cervical cancer HeLa cell line (Yuan and Walsh 2006). The 58 
anticancer or cytotoxic mechanism of polyphenols is still unclear; however, it has been 59 
suggested that polyphenols may inhibit the formation of mitotic spindles by preventing 60 
normal microtubule formation, decreasing angiogenesis and cell adhesion and 61 
invasion (Olivares-Bañuelos et al. 2019;  Zenthoefer et al. 2017; Wells et al. 2016). 62 
Seaweed flavonoids such as flavones, catechins, chalcones, flavanols and 63 
isoflavonoids are well recognised to exhibit a potent anticancer activity. For example, 64 
flavonoids extracted in methanol, chloroform and ethyl acetate from the brown algae 65 
Padina gymnospora, and Sargassum wightii reduced the cell viability of the human 66 
cancer cell lines  A549, HCT-15 and  PC-3 (Murugan and Iyer 2013). One possible 67 
mechanism of flavonoids may be exerted by altering steroid hormone production 68 
through inhibition of aromatase, preventing the development of cancer cells (Sithranga 69 
et al. 2010). 70 
Polysaccharides from seaweeds, such as sulphated laminarin, porphyran and 71 
fucoidan are naturally active as anticancer agents against human breast, gastric, liver, 72 
prostate, colon, lung and urinary bladder cancers and melanoma (Yamasaki- 73 
Miyamoto et al. 2009; Alekseyenko et al. 2007; Lowenthal and Fitton JH 2015). The 74 
suggested mechanism is that polysaccharides cause cell cycle arrest at the G0/G1 75 
phase (Senthilkumar et al. 2013). A number of proteins have been isolated from 76 
seaweed such as lectins, glycoproteins and phycobiliproteins which are the most 77 
studied as bioactive anticancer compounds against human lymphoma MCL, colon 78 
cancer Colo201 cells and cervix cancer HeLa cell lines ( Pangestuti and Kim 2015; 79 
Harnedy and FitzGerald 2011). They may be able to induce cell cycle arrest and inhibit 80 
the IGF-IR signalling pathway (Park et al. 2013).  81 
Given the wide range of compounds that they contain and initial evidence on the 82 
activities of those compounds, brown algae are a promising source of novel 83 
pharmaceutical compounds. Among the brown seaweeds, the genus Cystoseira 84 
contains about 40 species distributed widely in the Atlantic Ocean and Mediterranean 85 
Sea (De Sousa et al. 2017).  Crude extracts of different species have shown anti-86 
tumour activity against a wide variety of cancer cell lines. Cystoseira spp. provide a 87 
good source of polyphenolic compounds (De Sousa et al. 2017), which are well known 88 
to show cytotoxic activities against tumour cells (Gutiérrez-Rodríguez et al. 2017). 89 
Polyphenols from these algae include those with unique structural features and exhibit 90 
effective anticancer activities (Yong-Xin et al. 2011), for example, hexane fractions 91 
extracted from Cystoseira crinita and C. stricta showed 87% and 50% reductions in 92 
proliferation respectively in colorectal carcinoma (Caco2) cells after 72 h exposure with 93 
200 µgmL−1 extracts and the antiproliferative effect correlated with their polyphenol 94 
and flavonoid contents (Alghazeer et al. 2016).  95 
Several studies have demonstrated that the bioactivity properties of brown seaweeds 96 
vary seasonally (e.g. Stengel et al. 2011). These studies have indicated that changes 97 
in biotic and abiotic factors between seasons and locations affect the production of 98 
their bioactive compounds (Celis-Plá et al. 2016; Zatelli et al. 2018). However, as far 99 
as we are aware, while concentrations of secondary metabolites have been measured, 100 
no assessment of seasonal variations in cytotoxicity against cancer cell lines has been 101 
undertaken. Here, we investigate the seasonal variation of the chemical composition 102 
and the cytotoxic activity of extracts from C. tamariscifolia collected from south-west 103 
England. We show that extracts from C. tamariscifolia harvested in the winter and 104 
spring contained higher levels of secondary metabolites in accordance with previous 105 
work (Celis-Plá et al. 2016). Furthermore, we tested cytotoxicity of our extracts against 106 
leukaemia and prostate cancer cell lines and we show seasonal variation in the 107 
cytotoxic activity of four different solvent extracts against these cell lines. These 108 
cytotoxic activities can range from complete cell death to undetectable depending on 109 
the season and thus, we suggest that when considering collecting marine algae from 110 
temperate seas in order to search for bioactive compounds, a consideration of 111 
seasonality is made and samples are collected during different seasons to maximise 112 
the possibility of finding bioactive compounds. 113 
  114 
Material and methods 115 
Collection of Cystoseira tamariscifolia: 116 
Cystoseira tamariscifolia was collected by hand from the shallow subtidal at Hannafore 117 
Point, Cornwall, UK (DD N 50.342234, DD W -4.453528) in mid-June (summer), mid-118 
October (autumn), and early March (winter) and early May (spring). The collected 119 
samples were transferred to the laboratory in polythene bags kept in an icebox.  On 120 
arrival, the samples were rinsed with distilled water, cleaned of adhering debris and 121 
epiphytes and then freeze-dried at −20oC using Edwards super Modulyo freeze dryer. 122 
Solvent extraction 123 
Extracts were made in chloroform, methanol (100% and 70%) and water. Fifty grams 124 
of freeze-dried samples were mixed with solvents (1:10, w/v), and then homogenised 125 
for 2 min by using an IKA T10B Ultra-Turrax disperser at 24oC. The extract was then 126 
stirred for 3 min, centrifuged (5,000 g, 10 min, room temperature [RT] and the 127 
supernatants recovered. The extracts were dried at 40oC under vacuum. Solvents 128 
were used to re-suspend all extracts, and then the extracts were stored at −20oC for 129 
biological activity screening (Vizetto-Duarte et al. 2016). 130 
Total polyphenol content (TPC) 131 
The Folin-Ciocalteu (F-C) colourimetric technique (Velioglu et al. 1998) was used to 132 
determine total phenolic concentrations (TPC). Briefly, 5 µL of the extracts at 0.1, 1 133 
and 10 mg/mL were mixed with 100 µL of 10-fold diluted F–C reagent, incubated at 134 
RT for 5 min and mixed with 100 µL of sodium carbonate (75 g L-1, w/v). Following a 135 
90 min incubation period at RT, absorbance was measured at 725 nm on a microplate 136 
reader (Omega, BMG Labtech). The concentration of TPC was calculated as 137 
phloroglucinol equivalents (PGE) utilising a calibration curve prepared with 138 
phloroglucinol standard solutions and is expressed as mg PGE   g-1 dry weight. 139 
Total flavonoid content (TFC) 140 
Flavonoid concentrations were quantified according to the method described by Ahn 141 
et al. (2007), with modifications. Briefly, 50 µL of 2% (w/v) aluminium chloride–ethanol 142 
solution was added to 50 µL of the extracts at 0.1, 1, 10 mg mL-1. After one hour at RT, 143 
the absorbance was measured at 420 nm on a microplate reader (Omega, BMG 144 
Labtech). Quercetin was used as a standard, and results are expressed as mg of 145 
quercetin equivalents (QE) g-1 dry weight. 146 
Total polysaccharide content  147 
Total polysaccharide concentrations were measured by the phenol-sulfuric acid 148 
method (Masuko et al. 2005). 50 µL of samples at the concentrations 0.1, 1 and 10 149 
mg/mL was added to 150 µL of sulfuric acid (96% reagent grade). The mixture was 150 
incubated in a 96 well plate floating on a water bath at 90oC for 5 min. 30 µL of 5% 151 
phenol was added to the mixture for another 5 min in the water bath. The plate was 152 
then floated on cold water for additional 5 min to cool and the absorbance was 153 
measured at 490 nm on a microplate reader (Omega, BMG Labtech). Glucose was 154 
used as a standard and results are expressed as mg of glucose equivalents (G) g-1 dry 155 
weight. 156 
Total protein 157 
The BCA assay was carried out to determine total protein concentrations using the 158 
Pierce BCA Protein Assay Kit (Thermo Fisher Scientific) in a 96-well-plate format. The 159 
assay mixture contained 100 μL of the reagent and 100 μL of the sample; crude 160 
extracts at concentrations 0.1, 1 and 10 mg mL-1. A standard curve with serial bovine 161 
serum Albumin BSA solutions (ranging from 0.1 μg mL-1 to 100 μg mL-1) was used for 162 
calibration. The mixture was incubated at 37◦C and absorbance was measured at 560 163 
nm on a microplate reader (Omega, BMG Labtech).  164 
Cell line maintenance and culture 165 
The culturing of the human leukaemia cancer cell lines THP-1 and HL60 was as a 166 
suspension and the human prostate cancer cell line (PC3) was as a monolayer.  Cells 167 
were obtained from the European Collection of Authenticated Cell Cultures (ECACC), 168 
and divided every 3-4 d and were used regularly between passages 10-35. The cells 169 
were cultured in RPMI 1640 complete growth medium supplemented with 10% (v/v) 170 
fetal bovine serum and 2 mM L-glutamine and maintained at 37ºC, under 5% CO2 in a 171 
humidified incubator. 172 
 173 
Cell vitality assay 174 
The cells were incubated at a density of 2 x105 cells/well in a 96-well microplate for 72 175 
h at 37ºC with an equal volume of assay medium containing thiazolyl blue tetrazolium 176 
(2 mg mL-1 in PBS). The resulting formazan crystals were solubilised in 150 μL DMSO. 177 
The absorbance was read at 540 nm using a microplate reader (Omega, BMG 178 
Labtech). The IC50 values were calculated from a sigmoidal dose-response curve of 179 
the data generated in SigmaPlot v. 13.0. 180 
Fluorescent staining for HL60 and THP-1 cells 181 
THP-1 and HL60 were seeded at 106 cells/ml in 24-well culture plates and treated with 182 
100% methanol extracts of C. tamariscifolia for 48 h. Cells were centrifuged and 183 
suspended in PBS. Propidium iodide (5 μg mL-1in PBS; Sigma Aldrich) was used for 184 
staining cells for 5 min at room temperature in the dark and images were captured 185 
using a Nikon fluorescence microscope. 186 
Flow Cytometry Analysis 187 
Flow cytometry was performed to determine the apoptotic effect of C. tamariscifolia 188 
methanol extracts on human leukaemia cell lines HL 60 and THP-1. Cells were seeded 189 
at a density of 106 mL-1 and exposed to extracts at a concentration of 150 µg mL-1 190 
before being incubated at 37°C in a 5% CO2 incubator for 24h. Cells were washed in 191 
PBS and fixed in cold 70% ethanol for 1h. Cells were incubated in 50 μg mL-1 RNase 192 
and 50 μg mL-1 fluorescein diacetate (FITC; Sigma Aldrich) solution for 30 min before 193 
cells were analysed by Becton Dickinson FACSCalibur Flow Cytometer. All 194 
experiments were performed in three replicates.  195 
 196 
  197 
Results  198 
Effects of extraction method and season on the biochemical composition. 199 
To assess the cytotoxic bioactivity of Cystoseira tamariscifolia extracts from the south-200 
western coast of England, various extraction solvents were applied to material 201 
collected in all four seasons, and the concentrations of primary and secondary 202 
metabolites were measured (Table 1).  203 
100% methanol extracts of C. tamariscifolia contained the highest yields of primary 204 
and secondary metabolites. Polyphenol content was found to be higher in 100% 205 
methanol extracts with a concentration of approximately 100 mg g-1 DW, while 206 
chloroform extracts showed the highest content of flavonoids with up to 45 mg g-1 DW. 207 
Polysaccharide content ranged from 10 and 45 mg g-1 DW in the water and 100% 208 
methanol extracts, respectively (Table 1). 209 
The spring and summer extracts generally had higher concentrations of metabolites 210 
while in autumn we recorded the lowest concentration of total polyphenols and 211 
flavonoids. C. tamariscifolia crude extracts had low protein content compared with the 212 
previous bioactive compounds. The greatest concentration of protein was in the 213 
autumn in both 100% methanol and water extracts with concentrations of roughly 19 214 
and 6 mg g-1 DW respectively, while the chloroform extract could not be used due to 215 
interference with the assay. 216 
Extraction method and seasonality impact the anticancer activity of C. 217 
tamariscifolia extracts. 218 
We were interested in seeing the effect of the extraction method and season on any 219 
potential cytotoxic activity as Cystoseira spp. extracts have been shown to contain 220 
various bioactive compounds, particularly polyphenols that show cytotoxicity against 221 
cancer cell lines. Three different cell lines, HL-60, THP-1 and PC3 cells, representing 222 
two leukaemia-derived lines and a prostate cancer line respectively, were treated with 223 
increasing concentrations of C. tamariscifolia extracts and cell vitality was assessed 224 
via the MTT assay. Cells were treated with extracts from all four seasons extracted via 225 
all four extraction regimes separately (Figures 1, 2 and 3) and IC50 values for cell 226 
vitality were calculated (Table 2).   227 
The solvent used to make the extracts influenced the cytotoxic activity of the extracts. 228 
Generally, 100% methanol and chloroform extracts had the most cytotoxic effect on 229 
the three cell lines tested with some differences between them (Table 2). The 100% 230 
MeOH extract was approximately 17 times more cytotoxic in HL-60 compared to water 231 
extracts, while both 100% methanol and chloroform extracts had almost identical 232 
activity in HL60 and THP-1. Extracts made in water were the most cytotoxic in PC3 233 
cells (Figure 2) with IC50 values approximately 2-5 fold higher than for the other 234 
solvents whereas water extracts were much less cytotoxic than the other solvents for 235 
HL-60 and THP-1 cells, being between approximately 2-130 fold less cytotoxic 236 
(Figures 1, 3).    237 
In addition to the extraction method effect, there was a clear seasonality in the 238 
cytotoxic effects on the three different cell lines. Summer and spring extracts showed 239 
the most potent cytotoxic effect on THP-1 and HL-60 cells with approximately 8 times 240 
higher cytotoxicity compared to the autumn and winter extracts. There was, however, 241 
an exception in that winter extracts were also highly cytotoxic against the prostate 242 
cancer cells PC3.  243 
HL-60 cells showed the greatest sensitivity to C. tamariscifolia extracts with a mean 244 
IC50 over all seasons and extracts of 80.61 ± 21.74 µg mL-1 while the similar THP-1 245 
model showed a mean IC50 over all seasons and extracts of 199.78 ± 37.23 µg mL-1 246 
and PC3, 162.15 ± 36.11 µg mL-1. The highest cytotoxic activity was seen in the 247 
summer extracts in 100% and 70% MeOH and 100% chloroform on HL-60 cells (IC50 248 
values; 2.32 ± 0.21, 7.34 ± 0.30 and 7.92 ± 0.12 µg mL-1 respectively; Figure 1). These 249 
values show that the cytotoxic activity of these crude extracts is very high against HL-250 
60 cells and is between approximately 17 and 62 fold higher than the corresponding 251 
effects on THP-1 and PC3 cells, respectively.  252 
Methanol extracts of C. tamariscifolia induce apoptosis in HL60 and THP-1 Cell 253 
lines 254 
To investigate whether the cytotoxicity activity of C. tamariscifolia extracts is related to 255 
the induction of apoptosis, HL60 and THP-1 cells were exposed to a concentration of 256 
150 mgmL-1 of methanol extracts of C. tamariscifolia for 24 h and nuclear 257 
morphological changes of HL60 and THP-1 cells were observed using propidium 258 
iodide staining (Fig. 4). Compared with the normal nuclear morphology of the control 259 
cells, the cells treated with C. tamariscifolia extracts presented typical morphological 260 
characteristics of apoptosis, including nuclear fragmentation. Additional confirmation 261 
of apoptosis induced by methanol extracts of C. tamariscifolia was performed by flow 262 
cytometry-based on fluorescent diacetate (FITC) staining as shown in figure 5. Control 263 
cells that had not been treated with extract displayed a largely homogeneous 264 
population with >99% of cells being vital. Upon treatment with the extract, this dropped 265 
to 36.28 and 17.54% in HL-60 and THP-1 cells respectively and an increase in cells in 266 
both necrosis and late apoptosis was observed with c. 50% of cells in late apoptosis 267 
in both lines confirming the data from the cell vitality assay. 268 
  269 
Discussion 270 
In temperate seas, one would expect that seasonal differences would have a large 271 
influence on the concentrations of likely bioactive compounds and thus bioactivity of 272 
those extracts. Surprisingly, little work has been performed on these links. Here we 273 
have investigated the effects of season and extraction method on primary/secondary 274 
metabolite concentrations in extracts and their cytotoxic activity against three cancer 275 
cell lines.  276 
Methanol (100%) was generally the most effective solvent, extracting the highest 277 
levels of the four metabolite classes, although all four solvents gave detectable levels 278 
of all the investigated metabolites, the exception being chloroform that interfered with 279 
the BCA assay for proteins. Concentrations of polyphenols and flavonoids were high, 280 
a result in accordance with previous research showing brown algae to be good sources 281 
of these two metabolite classes (Thomas et al. 2011; Alghazeer et al. 2016).  A similar 282 
pattern of results was obtained by Mhadhebi et al. (2011) and Yegdaneh et al. (2016) 283 
who also concluded that methanol and chloroform extracts contain high concentrations 284 
of metabolites, especially polyphenols. This result can be explained by the difference 285 
in secondary metabolite polarity. For example, the high variation in the structures and 286 
both hydrophilic and hydrophobic parts of polyphenols (Li et al. 2011) allow them to be 287 
extracted typically in polar solvents including methanol and water but some can also 288 
be extracted in low polarity solvents such as chloroform (Airanthi et al. 2011; Vizetto-289 
Duarte et al. 2016), which may explain the high levels of polyphenols in chloroform 290 
extracts of Cystoseira. Protein represented the least common of the four classes of 291 
metabolite as might be expected in brown algae.  292 
As might be expected, there was a clear seasonality to the levels of the metabolites 293 
although this varied between compound and extraction method (Celis-Plá et al. 2016; 294 
Rickert et al. 2016; Cikoš et al. 2018). C. tamariscifolia begins to grow in late winter 295 
with most growth in the spring and summer before stopping in autumn. Polyphenols 296 
were highest in each extraction method in spring and summer except for chloroform 297 
extracts from winter. This is consistent with observations by Abdala-Díaz et al. (2006), 298 
who showed that polyphenol concentration in the tissue of C. tamariscifolia (in Spain 299 
from June 1988 to July 2000) ranged from 2% in the winter to 8% in summer. 300 
Polyphenols from species of the brown algal order Dictyotales, Fucales and 301 
Laminariales, have been correlated with the tissue age and stage of the life cycle and 302 
there were significantly lower levels in new branches in late winter than older, bigger 303 
branches in summer (Denton et al. 1990; Mannino et al. 2014). For flavonoids, 304 
polysaccharides and protein, the picture was more complex with winter and autumn 305 
often offering at least one higher value than in spring/autumn. The complexity of the 306 
variation of flavonoid, polysaccharide and protein levels extracted from C. 307 
tamariscifolia has been highlighted in previous studies. For instance, a study by 308 
Abdala-Díaz et al. (2006) found that spring and winter extracts of C. tamariscifolia 309 
showed the highest concentration of flavonoids, however, contradictory results were 310 
reported by Ramah et al. (2014) and Mannino et al. (2014) who showed that the 311 
flavonoid peak occurred in summer. During the year, the highest levels of 312 
polysaccharides in C. tamariscifolia were observed in summer, supporting the 313 
observations of Teas et al. (2013) and Hurtado and Critchley (2018). These authors 314 
noted that Undaria pinnatifida, Ascophyllum nodosum and Fucus vesiculosus showed 315 
the maximum levels of polysaccharides in summer. However, other results by 316 
Skriptsova (2016) revealed that Saccharina japonica and Sargassum pallidum showed 317 
maximum polysaccharide content in autumn. The protein content in C. tamariscifolia 318 
varied from 3.28 ± 0.36 to 19.57±1.42 mg g-1 dry weight, and it differs from season to 319 
season and according to the extraction method. In general, the highest protein values 320 
in C. tamariscifolia were found in autumn and spring, while the lowest were found 321 
winter and summer. Similar results were reported by Kim et al. (2011) and Pangestuti 322 
and Kim (2015), who suggested that minimum protein concentration in summer could 323 
be linked with protein destruction. 324 
Given the temperate nature of the collection site, autumn and winter offer lower water 325 
temperatures, fewer hours of sunlight and increased wave action that will lead to 326 
decreased growth and investment into primary and secondary metabolites (Fleurence 327 
and Levine 2016). This may also coincide with decreased pressures of herbivory 328 
during these seasons and less requirement for secondary metabolites (Duffy and Hay 329 
1990). We found that new growth of C. tamariscifolia was already clearly apparent in 330 
early March (winter) with many fresh new phosphorescent fronds present presumably 331 
ready for the increased sunlight hours of spring and summer. Conversely, in October 332 
(autumn) most of the thalli were showing early signs of senescence where the main 333 
axis and the primary laterals had elongated while the branches were relatively short 334 
and often covered in epiphytes. Despite this, autumn algae still contained high levels 335 
of some metabolites although polyphenol levels were generally lowest in autumn, but 336 
this depended on the extraction method. One explanation of this result could be 337 
attributed to the increase in the need for the secondary metabolites as a protection 338 
mechanism against increased herbivory in summer (Duffy and Hay 1990; Jormalainen 339 
and Honkanen 2008). Another reason for the increase in secondary metabolites in 340 
summer may be due to the photoprotective role against the high radiation dosages in 341 
summer daylight (Connan et al. 2004). They also contribute to protection against 342 
oxidative stress, bacterial infection and epiphytes and perform a role in algal 343 
reproduction which all increase in summer (Plouguerné et al. 2006; Ferreres et al. 344 
2012; Jennings and Steinberg 1997; Thomas et al. 2011).  345 
In line with Duarte (2016), who demonstrated that a hexane extract of C. tamariscifolia 346 
had a high level of cytotoxicity against AGS, HCT-15 and HepG2 cell lines with IC50 347 
values of 32.36, 23.59 and 13.15 μg mL-1 respectively, we showed that our extracts 348 
possess cytotoxic activity against cancer cell lines. In particular, our extracts were 349 
considerably more cytotoxic against HL-60 cells and our evidence suggests that cell 350 
death is induced via apoptosis. There is a large seasonal variation not only in the levels 351 
of primary and secondary metabolites but also a significant seasonal variation in their 352 
cytotoxic effects. In particular, our results clearly underline the need to test extracts 353 
from different seasons and using different solvent extraction protocols. Of particular 354 
interest, our data suggest that generalisations cannot be drawn with respect to season 355 
or extraction method and that there is no best season or extraction method when 356 
results are compared between cell types. For example, the difference between the 357 
effect of the summer extracts in organic solvents for HL-60 cells and the aqueous 358 
winter extracts on PC3 cells highlights this difference. Indeed, we carried out statistical 359 
analyses to examine any potential interactions between metabolite composition and 360 
the cytotoxicity of the extracts with season and extraction method (data not shown). 361 
There was no clear interaction that could link the cytotoxic effects to any metabolite 362 
group which might also suggest that various bioactive compounds may be present in 363 
the extracts and that their relative amounts may vary with both season and extraction 364 
method. It would be tempting to assume that summer (or an early or midpoint of the 365 
growing season) might be the best time to collect material, but our results show that 366 
this is not necessarily the case in all cell lines or extracts. We have not fully fractionated 367 
our extracts to isolate the specific compound(s), but it is likely that different compounds 368 
are responsible for the observed effects and that these change levels with season. 369 
Equally, we cannot discount that there may be synergistic interactions between 370 
compounds that only become apparent in different seasons. We believe that it is 371 
possible that many promising extracts potentially containing novel 372 
cytotoxic/chemotherapeutic agents may have been discarded in the past where 373 
samples were taken in a single season, extracted using a single solvent or tested using 374 
a single cell line. 375 
We suggest that, where possible, samples are taken at multiple times of the year that 376 
represent different phases in the growth or annual life cycle of the plant/species in 377 
question. Given that many of the bioactive compounds with potential medical use are 378 
probably produced in response to some type of biotic or abiotic stress, it may also be 379 
good practice to include the presence of any obvious stressors (seasonal temperature, 380 
irradiance, herbivores, for example) into any consideration of sampling times so as to 381 
maximize the possibility of finding novel compounds. 382 
 383 
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Table 1: Metabolite concentrations in Cystoseira tamariscifolia as a function of 
season and extraction solvent. DW: dry weight. Total polyphenol Content: milligram 
phloroglucinol acid equivalents per gram dry weight; Total flavonoid Content: 
milligram Quercetin equivalents per gram dry weight. Total polysaccharide: milligram 
Glucose equivalents per gram dry weight; Total protein: milligram Bovine Serum 




(mg g-1 DW) 
Season Extraction solvent 




Summer 102.23±1.85 57.70±2.06 83.24±1.03 41.99±0.90 
Autumn 71.27±4.16 9.67±1.27 20.61±3.07 7.81±0.31 
Winter 71.16±4.40 31.20±1.19 14.62±0.91 48.89±1.91 




Summer 22.87±0.80 5.55±0.46 8.56±0.71 22.27±0.66 
Autumn 27.86±1.20 3.26±0.27 5.99±0.99 16.69±0.52 
Winter 35.23±1.03 5.66±0.91 4.89±0.28 45.19±2.12 





Summer 48.84±3.66 8.16±0.40 14.95±1.85 42.84±3.84 
Autumn 31.10±5.80 11.19±0.96 10.25±1.58 27.81±0.71 
Winter 18.04±2.96 3.92±0.33 3.12±069 25.78±8.74 




Summer 9.28±0.28 8.10±0.59 7.18±0.63 - 
Autumn 19.57±1.42 3.31±0.81 13.51±1.08 - 
 Winter  9.95±0.36 5.95±0.31 3.28±0.36 - 
 Spring 11.17±0.12 5.36±0.43 3.7±0.07 - 
 542 
 543 
Table 2: IC50 values (µg mL-1) for extracts on HL60, PC3 and THP-1 cell lines. Cells 
were exposed for 72 h to crude extracts of the brown alga Cystoseira tamariscifolia 
collected in all seasons. IC50 values were calculated by sigmoidal dose-response of 
the data using SigmaPlot v. 13.0. 




HL60 7.33 ± 0.30 2.32 ± 0.21 7.9170 ± 0.12 293.54 ± 25 
PC3 452.01 ± 20 40.09 ± 3.40 112.28 ± 11 24.88 ± 0.21 




HL60 110.17 ± 9.6 110.43 ± 9.8 46.25 ± 39 221.51 ± 19 
PC3 469.76 ± 31 64.72 ± 5.3 263.59 ± 24 50.42 ± 5.6 




HL60 39.37 ± 3.2 74.86 ± 0.51 24.63 ± 0.13 149.93 ± 0.20 
PC3 168.27 ± 15 105.60 ± 12 149.88 ± 0.41 38.69 ± 2.7 




HL60 24.29 ± 0.27 24.28 ± 0.20 24.46 ± 0.19 128.38 ± 17 
PC3 190.75 ± 19 110.83 ± 15 99.35 ± 8.7 228.39 ± 22 
THP-1 74.98 ± 0.45 24.80 ± 0.31 74.84 ± 0.30 169.13 ± 16 
 544 
Figure 1: Dose-response curves for cell vitality in HL-60 cells. HL60 cells were exposed 545 
for 72 h to crude extracts of the brown alga Cystoseira tamariscifolia collected in all 546 
seasons. Black circles - 70% MeOH, white circles - 100% MeOH, chloroform - black 547 
triangles, white triangles - water. (mean ± SD; n = 9).  548 
  549 
  550 
551 
Figure 2: Dose-response curves for cell vitality in PC3 cells. PC3 cells were exposed 552 
for 72 h to crude extracts of the brown alga Cystoseira tamariscifolia collected in all 553 
seasons. Black circles - 70% MeOH, white circles - 100% MeOH, chloroform - black 554 
triangles, white triangles - water. (mean ± SD; n = 9). 555 
 556 
Figure 3: Dose-response curves for cell vitality in THP-1 cells. THP-1 cells were 557 
exposed for 72 h to crude extracts of the brown alga Cystoseira tamariscifolia collected 558 
in all seasons. Black circles, 70% MeOH, white circles, 100% MeOH, chloroform black 559 
triangles, white triangles water. (mean ± SD; n = 9).   560 
  561 
 562 
Figure 4: Fluorescent staining of cancer cell nuclei with propidium iodide. (A) HL60 563 
and (B) THP-1 were treated with 100% methanol summer extracts at 150 μg mL-1 for 564 
36h. Fragmented nuclei and apoptotic bodies were seen in the C tamariscifolia extract-565 
treated cells (b), but not in the control treatment (a). Magnification 200×, images 566 
representative of three independent experiments. 567 
 568 
 569 
Figure 5: The effect of C. tamariscifolia methanol extracts on the human leukaemia cell 570 
lines HL 60 (A) and THP-1 (B). HL 60 and THP-1 cells were resuspended in PBS and 571 
then RNase, and fluorescein diacetate (FITC) were added for 30 minutes, and cells 572 
were analysed by flow cytometry. Control cells (a) received no drug treatments. (b) 573 
Extract-treated HL60 and THP-1 cells. Early, late apoptosis and necrosis were found 574 
in treated cells but not in control. Experiments were carried out in three replicates. 575 
 576 
